1419 related articles for article (PubMed ID: 27930849)
1. Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.
Moreira CS; Silva AC; Novais JS; Sá Figueiredo AM; Ferreira VF; da Rocha DR; Castro HC
J Appl Microbiol; 2017 Mar; 122(3):651-662. PubMed ID: 27930849
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
3. Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione).
Novais JS; Rosandiski AC; de Carvalho CM; de Saules Silva LS; Dos S Velasco de Souza LC; Santana MV; Martins NRC; Castro HC; Ferreira VF; Gonzaga DTG; de Resende GO; de C da Silva F
Curr Top Med Chem; 2020; 20(2):121-131. PubMed ID: 31820692
[TBL] [Abstract][Full Text] [Related]
4. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
5. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrobial evaluation of amino sugar-based naphthoquinones and isoquinoline-5,8-diones and their halogenated compounds.
Dias FRF; Novais JS; Devillart TADNS; da Silva WA; Ferreira MO; Loureiro RS; Campos VR; Ferreira VF; de Souza MCBV; Castro HC; Cunha AC
Eur J Med Chem; 2018 Aug; 156():1-12. PubMed ID: 30006155
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study.
Gunes H; Gulen D; Mutlu R; Gumus A; Tas T; Topkaya AE
Toxicol Ind Health; 2016 Feb; 32(2):246-50. PubMed ID: 24097361
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment.
Ramzi A; Oumokhtar B; Ez Zoubi Y; Filali Mouatassem T; Benboubker M; El Ouali Lalami A
Biomed Res Int; 2020; 2020():6509740. PubMed ID: 33381566
[TBL] [Abstract][Full Text] [Related]
13. The antimicrobial spectrum of Xeroform
Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
[TBL] [Abstract][Full Text] [Related]
14. Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria.
Yang SC; Yen FL; Wang PW; Aljuffali IA; Weng YH; Tseng CH; Fang JY
Future Microbiol; 2017 Sep; 12():1059-1073. PubMed ID: 28799789
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
16. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens.
Condò C; Anacarso I; Sabia C; Iseppi R; Anfelli I; Forti L; de Niederhäusern S; Bondi M; Messi P
Nat Prod Res; 2020 Feb; 34(4):567-574. PubMed ID: 30317865
[TBL] [Abstract][Full Text] [Related]
18. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
Luther MK; Mermel LA; LaPlante KL
Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
[TBL] [Abstract][Full Text] [Related]
19. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
20. Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm.
Graziano TS; Cuzzullin MC; Franco GC; Schwartz-Filho HO; de Andrade ED; Groppo FC; Cogo-Müller K
PLoS One; 2015; 10(5):e0128098. PubMed ID: 26020797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
